Skip to content

Role of Kanyalohadi Vati and Kuberaksha Vati in Kashtartava (Dysmenorrhea)

"Comparative clinical evaluation of Kanyalohadi Vati and Kuberaksha Vati in Kashtartava"

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058558
Enrollment
100
Registered
2023-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

neha mamgain
Lead Sponsor
Uttarakhand ayurved university hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients with complaint of painful menses. 2.Having scanty or average menses alongwith symptoms like lower abdominal pain,low backache,nausea,vomiting,diarrhea,fainting

Exclusion criteria

Exclusion criteria: patientshaving organic pathology of uterus,carcinoma of endometrium,PID etc Hb Using OCPs or IUCD having excessive menses

Design outcomes

Primary

MeasureTime frame
improvement in severity of pain improvement in duration of painTimepoint: Before starting the trial drug During 1st menses after taking the trial drug During 2nd menses after taking the trial drug During 3rd menses after taking the trial drug During 4th menses without the trial drug

Secondary

MeasureTime frame
artava pramana rajasrava avadhi praseka(nausea) chhardi(vomiting) vibandh(constipation) atisara(diarrhea) shrama(fatigue) aruchi(loss of appetite) shirah shula(headache) vankshana shula,katishula,janushula swedadhikya(excessive sweating) tamodarshana(fainting)Timepoint: 0 day 1 month later 2 months later 3 months later 4 months later

Countries

India

Contacts

Public ContactNeha Mamgain

Gurukul campus, uttarakhand ayurved university

dr.kavyajain@gmail.com9902345121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026